YOLFTbeta
BioNeutra Global Corp

BioNeutra Global Corp

BGA · V · Consumer Defensive / Packaged Foods

0.03CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.03
Open0.03
Day Range0.03 – 0.03
52-Week Range0.03 – 0.03
Volume0
Market Cap1.39M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta0.98
50-Day Avg0.03
200-Day Avg0.03

About

BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEODr. Jianhua Zhu Ph.D.
  • Employees0
  • Headquarters1030 West Georgia St., Vancouver, BC, Canada, V6E 2Y3, Canada
  • Websitehttps://www.bioneutra.ca

Leadership

  • Dr. Jianhua Zhu Ph.D.Founder, CEO, President & Director
  • David Sun C.M.A., CPA, M.A.Chief Financial Officer
  • Sheri O'BrienVice President of Sales & Marketing

Financials

Income Statement

Currency: CAD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Revenue7.58M15.67M16.04M25.99M32.14M37.72M37.70M24.12M15.40M13.39M11.38M
Growth (%)-+106.83%+2.37%+61.99%+23.67%+17.34%-0.04%-36.03%-36.14%-13.05%-15.00%
Cost of Revenue4.00M8.60M9.00M16.77M24.90M27.31M37.06M20.17M12.51M11.04M7.24M
Gross Profit3.58M7.07M7.05M9.22M7.24M10.40M638.16K3.94M2.89M2.35M4.14M
Gross Margin47.21%45.11%43.93%35.46%22.53%27.58%1.69%16.36%18.77%17.54%36.40%
Operating Expense1.95M3.52M6.11M6.54M7.26M8.00M10.47M6.97M5.25M4.82M5.58M
Operating Income1.63M3.55M940.49K2.68M-22.64K2.40M-9.83M-3.03M-2.36M-2.47M-1.44M
Operating Margin21.49%22.66%5.86%10.31%-0.07%6.36%-26.08%-12.55%-15.29%-18.42%-12.64%
EBITDA----569.43K5.11M-10.10M-1.50M-1.12M-1.36M-351.91K
EBITDA Margin----1.77%13.56%-26.79%-6.21%-7.24%-10.16%-3.09%
Net Income678.86K5.11M179.50K1.08M-1.16M3.10M-12.44M-3.71M-2.83M-2.92M-2.11M
Net Income Margin8.96%32.61%1.12%4.15%-3.61%8.23%-33.01%-15.37%-18.37%-21.82%-18.52%
R&D166.72K108.93K400.74K386.68K227.52K476.73K440.35K257.31K11.59K16.42K146.31K
R&D as % of Total Revenue2.20%0.70%2.50%1.49%0.71%1.26%1.17%1.07%0.08%0.12%1.29%
Interest Expense00000563.88K596.26K433.15K390.64K450.32K697.23K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%1.50%1.58%1.80%2.54%3.36%6.13%

Balance Sheet

Currency: CAD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Assets6.17M13.82M26.78M36.60M30.97M39.99M34.02M23.68M21.08M19.78M15.77M
Total Liabilities4.25M3.19M11.59M20.81M17.01M21.93M29.27M22.98M22.12M23.54M21.96M
Total Equity1.93M10.64M15.19M15.78M13.96M18.06M4.75M700.92K-1.03M-3.76M-6.19M
Cash1.19M2.08M1.63M591.71K1.39M1.50M523.10K933.77K839.24K722.55K1.89M
Net Debt----8.62M7.44M7.06M6.14M6.05M6.11M5.65M

Cash Flow

Currency: CAD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Cash Flow1.01M1.41M481.50K1.02M2.25M2.91M707.55K1.43M271.05K838.39K683.42K
Investing Cash Flow-48.27K65.69K-10.53M-2.58M-2.01M-823.28K278.25K-26.45K-276.75K--
Financing Cash Flow127.22K-975.49K10.47M388.97K-85.97K-1.65M-1.66M-899.62K-298.03K-318.52K446.22K
Capital Expenditure15.19K58.49K9.73M2.34M1.98M770.65K143.53K28.63K276.75K203.85K19.32K
Free Cash Flow----232.59K2.08M470.15K1.36M-5.70K634.54K664.10K
Dividends Paid535.84K535.84K120.80K00000000
FCF to OCF----10.36%71.68%66.45%94.67%-2.10%75.69%97.17%
Dividend Paid to FCF----0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Sep 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual0.000.000.00-0.030.000.010.00-0.050.000.00-0.000.17-0.000.00-0.00-0.010.00-0.00-0.00-0.01-0.00-0.00-0.000.000.00-0.00-0.00-0.00-0.00-0.00-0.010.01-0.00-0.000.00-0.010.030.000.010.00-0.03-0.030.030.040.01-0.020.04-0.02-0.10-0.02-0.12-0.020.00-0.00-0.06-0.03-0.00-0.02-0.010.00-0.01-0.03-0.03-0.02-
Surprise-----------------------------------------------------------------
Timing----------------------------------------------------------------After-hours

Key Statistics & Ratios

Market Cap1.39M
Enterprise Value8.14M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.13
Price / Book11.60
EPS-0.02
Book Value-0.177
Revenue (TTM)10.86M
Gross Profit (TTM)4.65M
EBITDA-349.51K
Profit Margin-5.62%
Operating Margin-9.17%
Return on Equity-255.35%
Return on Assets-3.44%
Shares Outstanding46.45M
Shares Float45.92M
Beta0.98
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%